{
  "trial_id": "NCT01268553",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, baseline PAH medication (IV epoprostenol, IV treprostinil, SQ treprostinil), duration of PAH diagnosis, baseline mPAP, baseline RAP, NYHA/WHO functional class, baseline 6-minute walk distance, baseline cardiopulmonary exercise test (CPET) results, baseline symptom questionnaire scores, baseline prostanoid dose.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "6-minute walk distance",
          "baseline 6-minute walk distance"
        ],
        [
          "pulmonary vascular resistance",
          "baseline mPAP"
        ],
        [
          "peak oxygen consumption",
          "baseline cardiopulmonary exercise test (CPET) results"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Region of Enrollment",
        "ratio of minute ventilation to CO2 output",
        "The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR)"
      ],
      "remaining_candidate_features": [
        "gender",
        "baseline PAH medication (IV epoprostenol, IV treprostinil, SQ treprostinil)",
        "duration of PAH diagnosis",
        "baseline RAP",
        "NYHA/WHO functional class",
        "baseline symptom questionnaire scores",
        "baseline prostanoid dose"
      ]
    },
    "processed-gen-response": "Age, gender, baseline PAH medication (IV epoprostenol, IV treprostinil, SQ treprostinil), duration of PAH diagnosis, baseline mPAP, baseline RAP, NYHA/WHO functional class, baseline 6-minute walk distance, baseline cardiopulmonary exercise test (CPET) results, baseline symptom questionnaire scores, baseline prostanoid dose."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline 6-minute walk distance, Baseline cardiopulmonary exercise test (CPET) results, Baseline mean pulmonary arterial pressure (mPAP), Baseline right atrial pressure (RAP), Baseline dose of IV/SQ prostanoid, NYHA/WHO functional class,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "6-minute walk distance",
          "Baseline 6-minute walk distance"
        ],
        [
          "peak oxygen consumption",
          "Baseline cardiopulmonary exercise test (CPET) results"
        ]
      ],
      "remaining_reference_features": [
        "pulmonary vascular resistance",
        "ratio of minute ventilation to CO2 output",
        "The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Baseline mean pulmonary arterial pressure (mPAP)",
        "Baseline right atrial pressure (RAP)",
        "Baseline dose of IV/SQ prostanoid",
        "NYHA/WHO functional class"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Baseline 6-minute walk distance, Baseline cardiopulmonary exercise test (CPET) results, Baseline mean pulmonary arterial pressure (mPAP), Baseline right atrial pressure (RAP), Baseline dose of IV/SQ prostanoid, NYHA/WHO functional class"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Pulmonary Arterial Hypertension Diagnosis Duration, NYHA/WHO Functional Class, mPAP, RAP, Prostanoid Dose, Six-Minute Walk Distance, Cardiopulmonary Exercise Test Results, Symptom Questionnaire Scores.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "6-minute walk distance",
          "Six-Minute Walk Distance"
        ]
      ],
      "remaining_reference_features": [
        "pulmonary vascular resistance",
        "peak oxygen consumption",
        "ratio of minute ventilation to CO2 output",
        "The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Pulmonary Arterial Hypertension Diagnosis Duration",
        "NYHA/WHO Functional Class",
        "mPAP",
        "RAP",
        "Prostanoid Dose",
        "Cardiopulmonary Exercise Test Results",
        "Symptom Questionnaire Scores"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Pulmonary Arterial Hypertension Diagnosis Duration, NYHA/WHO Functional Class, mPAP, RAP, Prostanoid Dose, Six-Minute Walk Distance, Cardiopulmonary Exercise Test Results, Symptom Questionnaire Scores."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), NYHA/WHO functional class, 6-minute walk distance, cardiopulmonary exercise test (CPET) parameters, mean pulmonary artery pressure (mPAP), right atrial pressure (RAP), dose of parenteral prostanoid, duration of PAH treatment, presence of concomitant medical conditions.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "6-minute walk distance",
          "6-minute walk distance"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Region of Enrollment",
        "pulmonary vascular resistance",
        "peak oxygen consumption",
        "ratio of minute ventilation to CO2 output",
        "The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR)"
      ],
      "remaining_candidate_features": [
        "sex",
        "race",
        "ethnicity",
        "weight",
        "height",
        "body mass index (BMI)",
        "NYHA/WHO functional class",
        "cardiopulmonary exercise test (CPET) parameters",
        "mean pulmonary artery pressure (mPAP)",
        "right atrial pressure (RAP)",
        "dose of parenteral prostanoid",
        "duration of PAH treatment",
        "presence of concomitant medical conditions."
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), NYHA/WHO functional class, 6-minute walk distance, cardiopulmonary exercise test (CPET) parameters, mean pulmonary artery pressure (mPAP), right atrial pressure (RAP), dose of parenteral prostanoid, duration of PAH treatment, presence of concomitant medical conditions."
  }
}